Author:
Ranieri Marianna,Di Mise Annarita,Tamma Grazia,Valenti Giovanna
Reference129 articles.
1. Aquaretic effect of lixivaptan, an oral, non-peptide, selective V2 receptor vasopressin antagonist, in New York Heart Association functional class II and III chronic heart failure patients;Abraham;Journal of the American College of Cardiology,2006
2. Oral lixivaptan effectively increases serum sodium concentrations in outpatients with euvolemic hyponatremia;Abraham;Kidney International,2012
3. Lixivaptan safely and effectively corrects serum sodium concentrations in hospitalized patients with euvolemic hyponatremia;Abraham;Kidney International,2012
4. Receptor binding of oxytocin and vasopressin antagonists and inhibitory effects on isolated myometrium from preterm and term pregnant women;Akerlund;British Journal of Obstetrics and Gynaecology,1999
5. 5-Fluoro-2-methyl-N-[4-(5H-pyrrolo[2,1-c]-[1,4]benzodiazepin-10(11H)-ylcarbonyl)-3-chlorophenyl]benzamide (VPA-985): An orally active arginine vasopressin antagonist with selectivity for V2 receptors;Albright;Journal of Medicinal Chemistry,1998
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Computational Study on Conus Textile Conopeptides for Mediating Ion Channel Transport;Proceedings of the 2023 10th International Conference on Bioinformatics Research and Applications;2023-09-22
2. Expeditious entry into carbocyclic and heterocyclic spirooxindoles;Organic & Biomolecular Chemistry;2022